Healthcare provider profile · identity verified

Eli Rosen, MD

Family Practice · BROOKLYN, NY · NPI 1992786552

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	421	97
Lisinopril	Lisinopril	319	64
Rosuvastatin Calcium	Rosuvastatin Calcium	304	63
Metoprolol Succinate	Metoprolol Succinate	294	61
Levothyroxine Sodium	Levothyroxine Sodium	273	48
Amlodipine Besylate	Amlodipine Besylate	270	60
Eliquis	Apixaban	245	45
Losartan Potassium	Losartan Potassium	228	49
Metformin Hcl	Metformin Hcl	186	43
Omeprazole	Omeprazole	158	42
Famotidine	Famotidine	156	39
Furosemide	Furosemide	156	35
Jardiance	Empagliflozin	152	27
Tamsulosin Hcl	Tamsulosin Hcl	135	31
Ozempic	Semaglutide	119	16
Simvastatin	Simvastatin	116	31
Hydrochlorothiazide	Hydrochlorothiazide	114	30
Sertraline Hcl	Sertraline Hcl	101	17
Valsartan	Valsartan	95	16
Finasteride	Finasteride	93	20
Citalopram Hbr	Citalopram Hydrobromide	84	16
Mirtazapine	Mirtazapine	84	23
Metformin Hcl Er	Metformin Hcl	83	20
Clopidogrel	Clopidogrel Bisulfate	75	17
Allopurinol	Allopurinol	72	14
Chlorthalidone	Chlorthalidone	71	18
Doxazosin Mesylate	Doxazosin Mesylate	64	15
Pantoprazole Sodium	Pantoprazole Sodium	64	20
Gabapentin	Gabapentin	63	20
Glimepiride	Glimepiride	55	suppressed
Mounjaro	Tirzepatide	52	12
Ketoconazole	Ketoconazole	48	22
Metoprolol Tartrate	Metoprolol Tartrate	44	13
Mupirocin	Mupirocin	44	19
Zolpidem Tartrate	Zolpidem Tartrate	44	14
Warfarin Sodium	Warfarin Sodium	43	suppressed
Telmisartan	Telmisartan	42	12
Carvedilol	Carvedilol	41	12
Torsemide	Torsemide	41	12
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	32
Januvia	Sitagliptin Phosphate	36	suppressed
Azithromycin	Azithromycin	35	32
Cephalexin	Cephalexin	35	17
Entresto	Sacubitril/Valsartan	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Nifedipine Er	Nifedipine	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Ramipril	Ramipril	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	15
Xarelto	Rivaroxaban	33	suppressed
Meloxicam	Meloxicam	31	16
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Trazodone Hcl	Trazodone Hcl	30	11
Donepezil Hcl	Donepezil Hcl	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Gemtesa	Vibegron	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Zonisamide	Zonisamide	26	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Ceftriaxone	Ceftriaxone Sodium	24	suppressed
Mometasone Furoate	Mometasone Furoate	24	suppressed
Lacosamide	Lacosamide	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Repaglinide	Repaglinide	22	suppressed
Diltiazem Hcl	Diltiazem Hcl	20	suppressed
Brilinta	Ticagrelor	19	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Prednisone	Prednisone	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Memantine Hcl	Memantine Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Ciclopirox	Ciclopirox Olamine	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Colchicine	Colchicine	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Rufinamide	Rufinamide	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Risperidone	Risperidone	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	12
Edarbi	Azilsartan Medoxomil	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Abilify Maintena	Aripiprazole	12	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Primidone	Primidone	12	suppressed
Diazepam	Diazepam	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Linzess	Linaclotide	11	suppressed
Lyrica	Pregabalin	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error